# Neuralink — Healthcare Investment Intelligence

> medical_device · Series B. MedFuel Intel profile as of 2026-06-12.

Neuralink is an American neurotechnology company developing implantable brain-computer interfaces (BCIs), with the first human implant in 2024 and subsequent trials including voice and vision restoration.[1][3][5] The company has raised significant funding through multiple rounds, including Series B and later, positioning it as a leader in high-density electrode implantation via robotic surgery.[1][4]

## Key facts (as of 2026-06-12)
- Sector: medical_device
- Stage: Series B
- Website: https://neuralink.com

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/neuralink-2. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.